Analyst
Longevity Partners
Equibles does not estimate personal net worth.
Rupesh Tatiya is recorded as Analyst at Longevity Partners. Rupesh Tatiya has spoken on 1 earnings call across 1 company, most recently for Onesource Specialty Pharma Limited on July 25, 2026. The companies whose calls Rupesh Tatiya spoke on are classified in the Healthcare sector.
“The first question, Niraj, is on soft gelatin capsules. The capacity went from 800 million to 2.4 billion. It has been quite some time now. The business was around 550 crore kind of revenue.”
Longevity Partners
Analyst
Transcript header (unverified)
Onesource Specialty Pharma Limited
Biotechnology · Healthcare
Earnings Call for the Quarter Ended June 30, 2026
Onesource Specialty Pharma Limited
